Cargando…
Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations
PURPOSE: Inhaled drugs have been cornerstones in the treatment of chronic obstructive pulmonary disease (COPD) for decades and show a high prescription volume. Due to the local application, drug safety issues of these therapies are often underestimated by professionals and patients. Data about adver...
Autores principales: | Bergs, Ingmar, Just, Katja S., Scholl, Catharina, Dreher, Michael, Stingl, Julia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879805/ https://www.ncbi.nlm.nih.gov/pubmed/36484792 http://dx.doi.org/10.1007/s00228-022-03433-9 |
Ejemplares similares
-
Emergency Department Visits Due to Dyspnea: Association with Inhalation Therapy in COPD and Cases with Adverse Drug Reactions
por: Bergs, Ingmar, et al.
Publicado: (2022) -
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study
por: Just, Katja S., et al.
Publicado: (2020) -
Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)–Never Change a Running System?
por: Just, Katja S., et al.
Publicado: (2021) -
CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System—Results From the ADRED Study
por: Just, Katja S., et al.
Publicado: (2021) -
Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study
por: Just, Katja S., et al.
Publicado: (2023)